Locations:

Cleveland Clinic Performs World’s First DBS Surgery for Stroke Recovery

Patient doing well, stimulation to start in coming weeks

twitter-170104-17-neu-504-machado-650×450

Cleveland Clinic has performed the first deep brain stimulation (DBS) surgery in a patient for the purpose of restoring motor function following ischemic stroke.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

During a six-hour procedure on Dec. 19, 2016, a team led by Andre Machado, MD, PhD, implanted DBS electrodes in the cerebellum of the patient, who has severe post-stroke residual hemiparesis despite previous physical therapy. The patient has been discharged home feeling well and in stable condition.

Over the next few weeks, following adequate healing and recovery from the brain surgery, the patient will undergo physical therapy. After a few weeks of rehabilitation, the DBS device connected to the implanted electrodes will be turned on as the patient continues physical therapy. The patient will be monitored and evaluated regularly to determine whether and how DBS can enhance the effects of physical therapy.

The first-in-human operation is the initial case in an NIH-supported Cleveland Clinic trial of DBS for stroke recovery detailed previously on Consult QD.

“If this research succeeds, it is a new hope for patients who have remained paralyzed after a stroke,” says Dr. Machado, Chairman of Cleveland Clinic’s Neurological Institute and a neurosurgeon specializing in neuromodulation. “It is an opportunity to allow our patients to rehabilitate and gain function and independence. Our knowledge to date shows that deep brain stimulation can help the brain reorganize and adapt beyond what physical therapy alone can do. Our study’s goal is to boost rehabilitation outcomes beyond what physical therapy alone could achieve.”

More details about this initial case in the trial are available in a new Time magazine feature. Dr. Machado (shown in the foreground of the above photo) discusses the trial’s rationale and goals in this short Consult QD video.

Advertisement

Related Articles

Older man tending to houseplants

TEMPO-2 Trial Shows Promise for Tavapadon in Newly Diagnosed Parkinson’s Disease

The selective D1/D5 dopamine agonist provides symptom relief and improves daily function.

illustration of human brain with swirls of activity inside it
September 23, 2026/Neurosciences/Brain Health

Cleveland ADRC Renewal Boosts Research Into Alzheimer’s Progression

5-year funding award supports cohort expansion and deep phenotyping of AD and related dementias

young man meditating on a sofa
September 21, 2026/Neurosciences/Epilepsy

Lifestyle Interventions Show Promise as Adjunctive Epilepsy Management

Highest response rates seen with stress-lowering techniques like yoga, meditation and mindfulness

scan of brain anatomy with a blue arrow marking a point of interest
September 18, 2026/Neurosciences/Cerebrovascular

Pinpointing an Underrecognized Cause of Debilitating Headache

Digital subtraction myelography unveils often-overlooked but highly treatable underlying defect

medical students gathered around a large monitor showing a brain image
September 16, 2026/Neurosciences/Education

How Our New Building Will Double as a Neuro-Focused Mecca for Graduate Medical Education

Housing multidisciplinary clinicians in one leading-edge facility can transform GME along with patient care

stylized illustration of human spine against high-tech decorative background
September 14, 2026/Neurosciences/Spine Care

Promise and Progress in Using AI and Analytics to Improve Spine Surgery Practice

How ongoing efforts will be bolstered by Cleveland Clinic’s new Neurological Institute building

Man with polysomnography electrodes attached to his head
September 8, 2026/Neurosciences/Sleep Disorders

AI Model Stratifies Sleep-Based Risk and Clinical Outcomes

Foundation model reveals latent risk structures in sleep physiology that elude conventional metrics

portrait of Dr. Imad Najm against decorative background with podcast overlay
September 2, 2026/Neurosciences/Podcast

Integrating AI Into EEG Evaluation and Epilepsy Care (Podcast)

Where the field is moving and what Cleveland Clinic has in the works

Ad